BriaCell Therapeutics Corp. (BCTX)

BriaCell Therapeutics Statistics

Total Valuation

BCTX has a market cap or net worth of $25.53 million. The enterprise value is $19.59 million.

Market Cap	25.53M
Enterprise Value	19.59M

Important Dates

The last earnings date was Monday, December 16, 2024, after market close.

Earnings Date	Dec 16, 2024
Ex-Dividend Date	n/a

Share Statistics

BCTX has 44.20 million shares outstanding. The number of shares has increased by 21.51% in one year.

Current Share Class	44.20M
Shares Outstanding	44.20M
Shares Change (YoY)	+21.51%
Shares Change (QoQ)	+49.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	36.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	6.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.65

Current Ratio	1.65
Quick Ratio	1.65
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -536.81% and return on invested capital (ROIC) is -601.59%.

Return on Equity (ROE)	-536.81%
Return on Assets (ROA)	-129.07%
Return on Capital (ROIC)	-601.59%
Revenue Per Employee	n/a
Profits Per Employee	-$1.04M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.76% in the last 52 weeks. The beta is 1.82, so BCTX's price volatility has been higher than the market average.

Beta (5Y)	1.82
52-Week Price Change	-85.76%
50-Day Moving Average	0.80
200-Day Moving Average	1.28
Relative Strength Index (RSI)	38.46
Average Volume (20 Days)	2,369,901

Short Selling Information

The latest short interest is 688,346, so 1.56% of the outstanding shares have been sold short.

Short Interest	688,346
Short Previous Month	534,828
Short % of Shares Out	1.56%
Short % of Float	1.88%
Short Ratio (days to cover)	0.77

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.98M
Pretax Income	-6.04M
Net Income	-16.60M
EBITDA	-29.87M
EBIT	-29.98M
Earnings Per Share (EPS)	-$0.87

Balance Sheet

Cash & Cash Equivalents	5.79M
Total Debt	n/a
Net Cash	5.79M
Net Cash Per Share	$0.13
Equity (Book Value)	3.71M
Book Value Per Share	0.11
Working Capital	3.23M

Cash Flow

In the last 12 months, operating cash flow was -$23.48 million and capital expenditures -$456,801, giving a free cash flow of -$23.93 million.

Operating Cash Flow	-23.48M
Capital Expenditures	-456,801
Free Cash Flow	-23.93M
FCF Per Share	-$0.54

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.51%
Shareholder Yield	-21.51%
Earnings Yield	-65.01%
FCF Yield	-93.75%

Analyst Forecast

The average price target for BCTX is $15.00, which is 2,573.80% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	2,573.80%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 2, 2020. It was a reverse split with a ratio of 0.0033333:1.

Last Split Date	Jan 2, 2020
Split Type	Reverse
Split Ratio	0.0033333:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a